Trinity Biotech | TRIB - Selling And Administration Expenses


Trinity Biotech reported $5.78M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Bayer EUR 3.7B 356M Mar/2026
Bio-Rad Laboratories USD 212.4M 8.6M Mar/2026
EDAP TMS EUR 12.92M 4.1M Mar/2026
J&J USD 6.42B 381M Jun/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 4.26M 779K Mar/2026
Roche Holding CHF 6.37B 908M Jun/2026
Siemens EUR 3.56B 45M Mar/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Tosoh JPY 43.44B 1.04B Jun/2026
Trinity Biotech USD 5.78M 405K Dec/2025
Veracyte USD 55.71M 4.87M Jun/2026